Citation: Jl. Cleland, SOLVENT EVAPORATION PROCESSES FOR THE PRODUCTION OF CONTROLLED-RELEASE BIODEGRADABLE MICROSPHERE FORMULATIONS FOR THERAPEUTICS AND VACCINES, Biotechnology progress, 14(1), 1998, pp. 102-107
Citation: Bs. Kendrick et al., A TRANSIENT EXPANSION OF THE NATIVE-STATE PRECEDES AGGREGATION OF RECOMBINANT HUMAN INTERFERON-GAMMA, Proceedings of the National Academy of Sciences of the United Statesof America, 95(24), 1998, pp. 14142-14146
Authors:
KENDRICK BS
CLELAND JL
LAM X
NGUYEN T
RANDOLPH TW
MANNING MC
CARPENTER JF
Citation: Bs. Kendrick et al., AGGREGATION OF RECOMBINANT HUMAN INTERFERON-GAMMA - KINETICS AND STRUCTURAL TRANSITIONS, Journal of pharmaceutical sciences, 87(9), 1998, pp. 1069-1076
Authors:
JOHNSON OL
JAWOROWICZ W
CLELAND JL
BAILEY L
CHARNIS M
DUENAS E
WU CC
SHEPARD D
MAGIL S
LAST T
JONES AJS
PUTNEY SD
Citation: Ol. Johnson et al., THE STABILIZATION AND ENCAPSULATION OF HUMAN GROWTH-HORMONE INTO BIODEGRADABLE MICROSPHERES, Pharmaceutical research, 14(6), 1997, pp. 730-735
Authors:
CLELAND JL
MAC A
BOYD B
YANG J
DUENAS ET
YEUNG D
BROOKS D
HSU C
CHU H
MUKKU V
JONES AJS
Citation: Jl. Cleland et al., THE STABILITY OF RECOMBINANT HUMAN GROWTH-HORMONE IN POLY(LACTIC-CO-GLYCOLIC ACID) (PLGA) MICROSPHERES, Pharmaceutical research, 14(4), 1997, pp. 420-425
Citation: Fw. Okumu et al., THE EFFECT OF SIZE, CHARGE AND CYCLIZATION OF MODEL PEPTIDES ON THEIRIN-VITRO RELEASE FROM DL-PLGA MICROSPHERES, Journal of controlled release, 49(2-3), 1997, pp. 133-140
Authors:
CLELAND JL
DUENAS E
DAUGHERTY A
MARIAN M
YANG J
WILSON M
CELNIKER AC
SHAHZAMANI A
QUARMBY V
CHU H
MUKKU V
MAC A
ROUSSAKIS M
GILLETTE N
BOYD B
YEUNG D
BROOKS D
MAA YF
HSU C
JONES AJS
Citation: Jl. Cleland et al., RECOMBINANT HUMAN GROWTH-HORMONE POLY(LACTIC-CO-GLYCOLIC ACID) (PLGA)MICROSPHERES PROVIDE A LONG-LASTING EFFECT, Journal of controlled release, 49(2-3), 1997, pp. 193-205
Authors:
CLELAND JL
LIM A
BARRON L
DUENAS ET
POWELL MF
Citation: Jl. Cleland et al., DEVELOPMENT OF A SINGLE-SHOT SUBUNIT VACCINE FOR HIV-1 .4. OPTIMIZINGMICROENCAPSULATION AND PULSATILE RELEASE OF MN RGP120 FROM BIODEGRADABLE MICROSPHERES, Journal of controlled release, 47(2), 1997, pp. 135-150
Authors:
LEE HJ
RILEY G
JOHNSON O
CLELAND JL
KIM N
CHARNIS M
BAILEY L
DUENAS E
SHAHZAMANI A
MARIAN M
JONES AJS
PUTNEY SD
Citation: Hj. Lee et al., IN-VIVO CHARACTERIZATION OF SUSTAINED-RELEASE FORMULATIONS OF HUMAN GROWTH-HORMONE, The Journal of pharmacology and experimental therapeutics, 281(3), 1997, pp. 1431-1439
Citation: J. Yang et Jl. Cleland, FACTORS AFFECTING THE IN-VITRO RELEASE OF RECOMBINANT HUMAN INTERFERON-GAMMA (RHIFN-GAMMA) FROM PLGA MICROSPHERES, Journal of pharmaceutical sciences, 86(8), 1997, pp. 908-914
Citation: Xm. Lam et al., ANTIOXIDANTS FOR PREVENTION OF METHIONINE OXIDATION IN RECOMBINANT MONOCLONAL-ANTIBODY HER2, Journal of pharmaceutical sciences, 86(11), 1997, pp. 1250-1255
Authors:
BRAZIL BT
CLELAND JL
MCDOWELL RS
SKELTON NJ
PARIS K
HOROWITZ PM
Citation: Bt. Brazil et al., MODEL PEPTIDE STUDIES DEMONSTRATE THAT AMPHIPATHIC SECONDARY STRUCTURES CAN BE RECOGNIZED BY THE CHAPERONIN GROEL (CPN60), The Journal of biological chemistry, 272(8), 1997, pp. 5105-5111
Citation: Nb. Bam et al., MOLTEN GLOBULE INTERMEDIATE OF RECOMBINANT HUMAN GROWTH-HORMONE - STABILIZATION WITH SURFACTANTS, Biotechnology progress, 12(6), 1996, pp. 801-809
Authors:
JOHNSON OL
CLELAND JL
LEE HJ
CHARNIS M
DUENAS E
JAWOROWICZ W
SHEPARD D
SHAHZAMANI A
JONES AJS
PUTNEY SD
Citation: Ol. Johnson et al., A MONTH-LONG EFFECT FROM A SINGLE INJECTION OF MICROENCAPSULATED HUMAN GROWTH-HORMONE, Nature medicine, 2(7), 1996, pp. 795-799
Citation: Jl. Cleland et Ajs. Jones, STABLE FORMULATIONS OF RECOMBINANT HUMAN GROWTH-HORMONE AND INTERFERON-GAMMA FOR MICROENCAPSULATION IN BIODEGRADABLE MICROSPHERES, Pharmaceutical research, 13(10), 1996, pp. 1464-1475
Citation: Ajs. Jones et Jl. Cleland, TECHNICAL AND REGULATORY HURDLES IN DELIVERY ASPECTS OF MACROMOLECULAR DRUGS, Journal of controlled release, 41(1-2), 1996, pp. 147-155
Authors:
CLELAND JL
BARRON L
BERMAN PW
DAUGHERTY A
GREGORY T
LIM A
VENNARI J
WRIN T
POWELL MF
Citation: Jl. Cleland et al., DEVELOPMENT OF A SINGLE-SHOT SUBUNIT VACCINE FOR HIV-1 .2. DEFINING OPTIMAL AUTOBOOST CHARACTERISTICS TO MAXIMIZE THE HUMORAL IMMUNE-RESPONSE, Journal of pharmaceutical sciences, 85(12), 1996, pp. 1346-1349
Authors:
CLELAND JL
BARRON L
DAUGHERTY A
EASTMAN D
KENSIL C
LIM A
WEISSBURG RP
WRIN T
VENNARI J
POWELL MF
Citation: Jl. Cleland et al., DEVELOPMENT OF A SINGLE-SHOT SUBUNIT VACCINE FOR HIV-1 .3. EFFECT OF ADJUVANT AND IMMUNIZATION SCHEDULE ON THE DURATION OF THE HUMORAL IMMUNE-RESPONSE TO RECOMBINANT MN GP120, Journal of pharmaceutical sciences, 85(12), 1996, pp. 1350-1357
Authors:
CLELAND JL
KENSIL CR
LIM A
JACOBSEN NE
BASA L
SPELLMAN M
WHEELER DA
WU JY
POWELL MF
Citation: Jl. Cleland et al., ISOMERIZATION AND FORMULATION STABILITY OF THE VACCINE ADJUVANT QS-21, Journal of pharmaceutical sciences, 85(1), 1996, pp. 22-28